
Pharmacology, pharmacogenomics, drug discovery and design, drug therapy [112]


Mathilde Dusseaux
Human Disease Models core facility

UV-VIS CARY 3500 COMPACT PELTIER • Agilent Technologies • UV-VIS CARY 3500 COMPACT PELTIER
Bioorganic chemistry of nucleic acids
Stéphane Pelleau
Infectious Disease Epidemiology and Analytics
My research interests focus on the interaction between malaria parasites and its human host through the analysis of biological mechanisms such as drug resistance or immunity that have an impact on disease epidemiology and […]

New clinical endpoints in primary Sjögren’s Syndrome: an interventional trial based on stratifying patients (NECESSITY)
Benno Schwikowski

Docking method based on saturation transfer difference NMR data, and means for its implementation WO 2019/011987
Nadia Izadi-Pruneyre • Michael Nilges

Anne-Cecile Petit
Perception & Action
Dr Anne-Cécile Petit is Associate Professor (MCU-PH) of embryology at Université Paris Cité and psychiatrist at GHU Paris – hôpital Sainte-Anne. Her research focuses on understanding the pathophysiological mechanisms of mood disorders, particularly depression, […]

EU-AIMS
Thomas Bourgeron

MECANICOC
Uwe Maskos • Pierre-Jean Corringer • Marie-Agnès Dillies

Marie Prevost
Signaling and receptors dynamics
I am a permanent researcher focusing on the understanding of the structure-function relationships of the human nicotinic receptors, and their role psychiatric and neurological diseases. We combine biochemistry, nanobodies engineering, cryo-electron microscopy, biophysics and […]

Paola Arimondo
UMR3523 – Chemistry for Life Sciences (Chem4Life)
Epigenetics defines when and where genes are expressed. Epigenetic marks are reversible and inheritable, integrate the impact of the environment and provide cellular plasticity. Aberrant epigenetic patterns are involved in tumor formation, maintenance and […]

ATIP-Avenir: Unravelling the role of erythrocyte deformability in Plasmodium falciparum transmission

Drug-induced mechanical clearance of gametocytes in the spleen

Deciphering dormancy in Cryptocococcus neoformans
Alexandre Alanio

Virgile Andreani
Physicist and computer scientist by training, I develop quantitative population models of antibiotic resistance, which I calibrate using optimal experimental design. I then exploit them to engineer optimal treatment strategies.

Dorian Obino
Macrophages and Endothelial Cells
Born and raised in the south of France, I moved to Paris to study at the Magistère Européen de Génétique (Université Paris VII, now Université Paris Cité) where I specialized in immuno-genetics and cell biology. […]